BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 26057451)

  • 1. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
    Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K
    Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating exosomal microRNAs as biomarkers of colon cancer.
    Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
    PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
    Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
    Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
    Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
    J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
    Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
    J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer.
    Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L
    Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
    Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
    Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
    Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
    PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.
    Karimi N; Ali Hosseinpour Feizi M; Safaralizadeh R; Hashemzadeh S; Baradaran B; Shokouhi B; Teimourian S
    J Chin Med Assoc; 2019 Mar; 82(3):215-220. PubMed ID: 30913118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
    Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.